• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

实体器官移植受者中艰难梭菌相关性腹泻的预防和治疗。

Prevention and Treatment of Clostridium difficile-Associated Diarrhea in Solid Organ Transplant Recipients.

机构信息

Division of Infectious Diseases, Emory University School of Medicine, 101 Woodruff Circle, WMB #2101, Atlanta, GA 30322, USA.

Division of Infectious Diseases, Emory University School of Medicine, 101 Woodruff Circle, WMB #2101, Atlanta, GA 30322, USA.

出版信息

Infect Dis Clin North Am. 2018 Sep;32(3):733-748. doi: 10.1016/j.idc.2018.05.001.

DOI:10.1016/j.idc.2018.05.001
PMID:30146033
Abstract

Clostridium difficile infection is a significant cause of morbidity and mortality in solid organ transplant recipients. Risk factors in this population include frequent hospitalizations, receipt of immunosuppressive agents, and intestinal dysbiosis triggered by several factors, including exposure to broad-spectrum antimicrobials. The incidence and potential for significant adverse outcomes among solid organ transplant recipients with C difficile infection highlight the evolving need for strategic C difficile infection risk factor modification and novel approaches to disease management in this patient population. This review focuses on current concepts related to the prevention and treatment of C difficile infection in solid organ transplant recipients.

摘要

艰难梭菌感染是实体器官移植受者发病率和死亡率的重要原因。该人群的危险因素包括频繁住院、接受免疫抑制剂治疗以及多种因素引发的肠道菌群失调,包括暴露于广谱抗生素。艰难梭菌感染的实体器官移植受者的发病率和潜在严重不良后果突出了在该患者人群中不断发展的对艰难梭菌感染危险因素修正和疾病管理新方法的战略需求。本综述重点介绍与实体器官移植受者艰难梭菌感染的预防和治疗相关的当前概念。

相似文献

1
Prevention and Treatment of Clostridium difficile-Associated Diarrhea in Solid Organ Transplant Recipients.实体器官移植受者中艰难梭菌相关性腹泻的预防和治疗。
Infect Dis Clin North Am. 2018 Sep;32(3):733-748. doi: 10.1016/j.idc.2018.05.001.
2
Clostridium difficile infection in solid organ transplant recipients.实体器官移植受者中的艰难梭菌感染
Curr Opin Organ Transplant. 2017 Aug;22(4):314-319. doi: 10.1097/MOT.0000000000000430.
3
Management of Clostridioides (formerly Clostridium) difficile infection (CDI) in solid organ transplant recipients: Guidelines from the American Society of Transplantation Community of Practice.实体器官移植受者艰难梭菌(以前称为梭状芽孢杆菌)感染(CDI)的管理:美国移植学会实践社区指南。
Clin Transplant. 2019 Sep;33(9):e13564. doi: 10.1111/ctr.13564. Epub 2019 Jun 20.
4
Fecal microbiota transplantation for recurrent Clostridium difficile infection in hematopoietic stem cell transplant recipients.造血干细胞移植受者复发性艰难梭菌感染的粪便微生物群移植
Transpl Infect Dis. 2016 Aug;18(4):628-33. doi: 10.1111/tid.12550. Epub 2016 Jul 5.
5
Frequency and risks associated with Clostridium difficile-associated diarrhea after pediatric solid organ transplantation: a single-center retrospective review.儿童实体器官移植后艰难梭菌相关性腹泻的发生率及相关风险:一项单中心回顾性研究
Transpl Infect Dis. 2016 Oct;18(5):706-713. doi: 10.1111/tid.12584. Epub 2016 Sep 16.
6
Comparison of outcomes with vancomycin or metronidazole for mild-to-moderate Clostridium difficile associated diarrhea among solid organ transplant recipients: A retrospective cohort study.实体器官移植受者中,万古霉素与甲硝唑治疗轻至中度艰难梭菌相关性腹泻的疗效比较:一项回顾性队列研究。
Transpl Infect Dis. 2018 Jun;20(3):e12867. doi: 10.1111/tid.12867. Epub 2018 Mar 30.
7
Clostridium difficile disease in solid organ transplant recipients: a recommended treatment paradigm.实体器官移植受者艰难梭菌病:推荐的治疗模式。
Curr Opin Organ Transplant. 2020 Aug;25(4):357-363. doi: 10.1097/MOT.0000000000000778.
8
Clostridium difficile in Immunocompromised Hosts: A Review of Epidemiology, Risk Factors, Treatment, and Prevention.免疫功能低下宿主中的艰难梭菌:流行病学、危险因素、治疗和预防的综述。
Clin Infect Dis. 2019 May 30;68(12):2144-2153. doi: 10.1093/cid/ciy845.
9
Postoperative antimicrobials after lung transplantation and the development of multidrug-resistant bacterial and Clostridium difficile infections: an analysis of 500 non-cystic fibrosis lung transplant patients.肺移植术后抗菌药物使用与多重耐药菌及艰难梭菌感染的发生:500例非囊性纤维化肺移植患者的分析
Clin Transplant. 2016 Jul;30(7):767-73. doi: 10.1111/ctr.12746. Epub 2016 May 6.
10
[Refractory colitis by Clostridium difficile treated with fecal microbiota transplant].[艰难梭菌所致难治性结肠炎经粪便微生物群移植治疗]
Medicina (B Aires). 2019;79(4):291-294.

引用本文的文献

1
Bring it on: Top five antimicrobial stewardship challenges in transplant infectious diseases and practical strategies to address them.来吧:移植传染病中抗菌药物管理的五大挑战及应对的实用策略。
Antimicrob Steward Healthc Epidemiol. 2022 Apr 27;2(1):e72. doi: 10.1017/ash.2022.53. eCollection 2022.